SIGLEC12 and pancreatic adenocarcinoma: In contrast, colon adenocarcinoma (COAD), lung adenocarcinoma (LUAD), lung squamous cell adenocarcinoma (LUSC), and pancreatic adenocarcinoma (PAAD) exhibited downregulation of SIGLEC12 when compared to healthy samples (Fig. 2).